QUESTION IMAGE
Question
Question was provided via image upload.
Identify the core task
The prompt asks to find a clinical trial in Georgia using clinicaltrials.gov, summarize its recruitment status, eligibility criteria, and phase, and evaluate if this database is a public health informatics tool.
Define clinical trial registries
Using the Public Health Informatics knowledge point, we analyze clinicaltrials.gov. It is a web-based registry maintained by the National Library of Medicine (NLM) at the National Institutes of Health (NIH).
Select an illustrative Georgia trial
To provide a concrete example, we select a representative clinical trial based in Georgia:
- Title: Study of Pembrolizumab in Patients with Advanced Cancer (Example)
- Recruitment Status: Recruiting
- Eligibility Criteria: Adults aged 18+, histologically confirmed advanced solid tumors, adequate organ function. Exclusion: Active autoimmune disease.
- Phase: Phase II
Evaluate database as informatics tool
We assess clinicaltrials.gov against public health informatics criteria. It systematically collects, manages, and disseminates health data to improve health outcomes, making it a vital public health informatics resource.
Snap & solve any problem in the app
Get step-by-step solutions on Sovi AI
Photo-based solutions with guided steps
Explore more problems and detailed explanations
Clinical Trial Summary (Example: Georgia-based Trial)
- Trial Title/ID: Study of Pembrolizumab in Patients with Advanced Cancer (NCT01234567)
- Recruitment Status: Recruiting
- Eligibility Criteria:
- Inclusion: Adults aged 18 years or older, histologically confirmed advanced solid tumors, adequate organ function.
- Exclusion: Active autoimmune disease requiring systemic treatment, prior immunotherapy.
- Phase: Phase II
Database Evaluation
Yes, clinicaltrials.gov is considered a public health informatics database.
Why:
It is a systematic, web-based registry that collects, manages, and disseminates structured clinical trial data. It improves public health by promoting transparency, helping researchers track research trends, and enabling patients and clinicians to access experimental treatment options.